Recital 2, Regulation (EU) 2021/572

In forcesince 20 Jan 2021

The use of protein hydrolysates as a source of protein in infant formula and follow-on formula has been allowed under Commission Directive 2006/141/EC [Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending Directive 1999/21/EC (OJ L 401, 30.12.2006, p. 1).]. However, in its opinion on the essential composition of infant and follow-on formulae [EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2014. Scientific Opinion on the essential composition of infant and follow-on formulae. EFSA Journal 2014;12(7):3760.], the European Food Safety Authority (‘Authority’) noted that the safety and suitability of each specific formula containing protein hydrolysates has to be established by clinical evaluation.

  • celex=31999L0021
  • celex=32006L0141
  • num:eu=2006/141